Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast Ophthalmic Solution 5.0% on Tear Film Biomarkers in Dry Eye Disease
NCT07490535Phase 4Not yet recruiting
- Sponsor
- Pittsburgh Research Institute
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lifitegrast in dry eye disease (DED), sponsored by Pittsburgh Research Institute. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
lifitegrast
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07490535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07490535.